Back to Results

A Phase 4 Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients with Polyneuropathy of Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with a V122I or T60A Mutation

Study category: Brain and Nervous System

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Phase

IV - Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.

Type of Study

Observational

Location

University of Colorado Hospital

Principal Investigator
Dianna Quan

Dianna Quan

Study ID

Protocol Number: 19-3061

More information available at ClinicalTrials.gov: NCT04201418

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers